Press Release Johnson & Johnson’s RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer Johnson & Johnson · Jul 30
Press Release MAINGEAR Unveils Next-Gen ‘Zero’ Gaming Desktop PCs: Engineered for Unrelenting Performance, Designed for Unobstructed Visibility MAINGEAR · Jul 30
Press Release C4® Expands Beyond Energy Drinks with the Launch of Sparkling Protein Nutrabolt · Jul 30
Press Release Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson’s Disease Aspen Neuroscience, Inc. · Jul 30
Press Release Nomad Foods to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 Nomad Foods Limited · Jul 30
Press Release Beauty Creations Lands at CVS Pharmacy, Marking Its Biggest Retail Milestone Yet Beauty Creations Cosmetics · Jul 30
Press Release New Clinical Research Presented at NUTRITION 2026 Shows Superbrewed Food’s Postbiotic Cultured Protein Matches Whey in Muscle-Building Response Superbrewed Food Inc. · Jul 30
Press Release BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor BioAdaptives, Inc. · Jul 30
Press Release Health-E Commerce® Expands Beyond E-Commerce with Launch of Patiently™ Telehealth Platform Offering Personalized, FSA/HSA Eligible Weight Loss and Menopause Support Health-E Commerce · Jul 30
Press Release Rio Grande Resources Announces Market Awareness Initiative and Engages with LFG Equities Corp. Rio Grande Resources · Jul 30
Press Release Leading Sports Goods Retailer Expands Investment in Bridgeline’s HawkSearch Platform Bridgeline Digital · Jul 30
Press Release Polaris Renewable Energy Declares Quarterly Dividend Polaris Renewable Energy Inc. · Jul 30